🔍 Observations
Topline
- Total Revenue from Operations grew 16.7% YoY (₹9,554 → ₹11,147 Cr), anchored by Interest Income rising 17.0% (₹8,986 → ₹10,512 Cr) as the loan book expanded sharply.
- Fees & commission income surged 47.7% YoY (₹201 → ₹297 Cr), signalling improving cross-sell and processing fee capture.
- QoQ revenue was nearly flat (₹2,884 → ₹2,903 Cr, +0.7%), indicating sequential momentum has plateaued near-term.
Bottomline
- PAT grew 18.4% YoY (₹2,163 → ₹2,560 Cr), outpacing revenue growth — a positive operating leverage signal.
- Q4FY26 PAT of ₹669 Cr grew 14.1% YoY (vs. ₹587 Cr Q4FY25) and was marginally ahead of Q3FY26 (₹665 Cr), showing steady quarterly earnings.
- Effective tax rate for FY26 was 22.9% (₹760 Cr tax on ₹3,320 Cr PBT), slightly elevated vs. FY25’s 21.9% — partly due to absence of prior-year tax credits (₹25 Cr benefit in FY25).
Margins
- Net Profit Margin improved modestly to 22.96% in FY26 vs. 22.64% in FY25 — limited expansion despite volume growth, as Finance Costs scaled proportionally (₹5,979 → ₹6,759 Cr, +13.1%).
- Impairment on financial instruments more than tripled YoY (₹58 → ₹191 Cr), creating a drag on pre-provision profitability — though absolute NPA ratios remain benign.
- Cost-to-income compression is gradual: Employee + Other expenses grew 13.5% YoY (₹693 → ₹807 Cr) vs. 16.7% revenue growth — marginal operational efficiency gain.
Growth Trajectory
- Loan book grew 24.3% YoY (₹99,513 → ₹1,23,745 Cr), significantly ahead of revenue growth, implying some yield compression or mix shift.
- EPS grew 15.0% YoY (₹2.67 → ₹3.07), with no equity dilution in FY26 (share capital unchanged at ₹8,329 Cr) — full growth accrues to existing shareholders.
- CRAR compressed sharply from 28.24% to 22.46%, a 578 bps decline YoY — rapid balance sheet expansion is consuming regulatory capital headroom.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Loan book at ₹1.24 lakh Cr (+24.3% YoY) — volume-driven topline runway remains strong in an underpenetrated housing finance market.
- Gross NPA at 0.27%, Net NPA at 0.11% — among the best asset quality ratios in Indian HFC/NBFC space; credit culture is demonstrably strong.
- PAT growth (18.4%) outpacing revenue growth (16.7%) — operating leverage beginning to manifest at scale.
- Zero equity dilution in FY26 — EPS growth is organic, not arithmetic; shareholder value creation is real.
- Fees & commission income +47.7% YoY — non-interest income diversification reduces dependence on spread-based earnings.
- Net Worth strengthened to ₹22,523 Cr — retained earnings alone added ~₹2,576 Cr to equity base, improving long-term solvency.
- LCR at 146.1% — comfortably above RBI’s 100% minimum threshold, reflecting prudent liquidity management.
🔴 Red Flags
- CRAR dropped from 28.24% → 22.46% — at this pace of balance sheet growth, capital raise or earnings retention alone may not sustain regulatory buffers; equity issuance risk is rising.
- Impairment charge tripled to ₹191 Cr (FY25: ₹58 Cr) — even with low NPA ratios, forward-looking provisioning is accelerating; warrants monitoring for credit cycle turn.
- Debt-Equity ratio rose to 4.60x from 4.11x — leverage is moving in the wrong direction as borrowings outpace equity accretion.
- Operating cash outflow deepened to ₹(19,895) Cr vs. ₹(17,075) Cr — entirely loan-book-led, but the widening gap underscores funding dependency on capital markets.
- Net gain on fair value changes fell 47.4% YoY (₹164 → ₹86 Cr) — treasury income headwind; not replaceable at scale.
- Finance costs growing at 13.1% YoY — as borrowings reprice upward or refinancing occurs, NIM compression risk persists if lending yields don’t keep pace.
📊 Balance Sheet Analysis
- Asset quality is pristine: Gross Stage 3 at 0.27% and Net Stage 3 at 0.11% with 59.78% PCR — credit book is clean and well-provisioned.
- Capital adequacy under pressure: CRAR at 22.46% vs. 28.24% a year prior; while still above regulatory minimums, the 578 bps compression in one year from aggressive loan book expansion is a structural concern.
- Leverage is rising: Total Debt-to-Assets at 0.82x; total borrowings (debt securities + other borrowings) at ₹1,03,657 Cr vs. equity of ₹22,523 Cr — leaves thin buffer for credit stress scenarios.
- Liquidity is adequate: Cash equivalents grew to ₹162 Cr; LCR at 146% and diversified borrowing mix (debt securities ₹51,015 Cr + other borrowings ₹52,642 Cr) reduces concentration risk.
💰 Cash Flow Analysis
- Operating cash burn of ₹(19,895) Cr reflects the business model reality — HFCs are structurally cash-consumptive as loan disbursements dwarf collections; the ₹24,218 Cr net loan outflow is the primary driver.
- Cash generated before working capital changes was ₹3,789 Cr (vs. ₹2,964 Cr FY25, +27.8%) — underlying pre-disbursement profitability is improving.
- Financing activities generated ₹21,197 Cr, comprising net long-term borrowings of ₹17,629 Cr and net short-term borrowings of ₹3,572 Cr — growth is entirely debt-funded; FY25 had ₹5,560 Cr equity infusion that is absent in FY26.
- Net cash position improved by ₹100 Cr to ₹162 Cr — a thin absolute buffer, typical for NBFCs with ALM-managed liquidity, but dependency on continuous debt market access is absolute.
💡 Investment Outlook
BAJAJHFL delivers consistent, high-quality compounding — 18.4% PAT growth, sub-0.3% NPAs, and a clean equity base — making it a premium HFC compounder.
The core risk is capital intensity: CRAR compression to 22.46% signals a capital raise could be 12–18 months away, which would dilute EPS unless accompanied by proportionate ROE expansion.
The tripling of impairment charges, while still low in absolute terms, is a leading indicator to track as the loan book seasons beyond ₹1 lakh Cr.
Investors with a 3-year horizon can view this as a structural beneficiary of India’s housing credit gap, provided management navigates the capital adequacy cycle without excessive dilution.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial spreadsheets, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.